TELA BIO
TELA Bio is a life science company that specializes in soft tissue reconstruction. The company aims to commercialize a portfolio of products that are purposefully designed to address a range of unmet needs in soft tissue repair.
TELA BIO
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2012-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.telabio.com
Total Employee:
101+
Status:
Active
Contact:
484-320-2930
Email Addresses:
[email protected]
Total Funding:
230.45 M USD
Technology used in webpage:
Domain Not Resolving Google Maps IPv6 Pound Sterling COVID-19 HubSpot CMS Hub Hubspot Hosted Akamai Hosted Comcast
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Elanix Biotechnologies
Elanix Biotechnologies is a life sciences company that specializes in tissue regeneration products.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Immunome
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.
Kernel
Kernel is a neuroscience company that specializes in developing brain-recording technologies.
M2 Ingredients
M2 Ingredients is a food production company that produces organic and whole food powdered and medical mushrooms.
Monocl
Monocl empowers life science professionals with the complete global expert solution for impactful outreach and strategic engagement.
Southern Research
A Non-profit Scientific research organization .
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Post-IPO Equity - TELA Bio
MidCap Financial
MidCap Financial investment in Post-IPO Debt - TELA Bio
Checkmate Capital
Checkmate Capital investment in Series B - TELA Bio
ProMedica Health System
ProMedica Health System investment in Venture Round - TELA Bio
Quaker Partners
Quaker Partners investment in Venture Round - TELA Bio
OrbiMed
OrbiMed investment in Venture Round - TELA Bio
Pacira Pharmaceuticals
Pacira Pharmaceuticals investment in Venture Round - TELA Bio
Signet Healthcare Partners
Signet Healthcare Partners investment in Venture Round - TELA Bio
Key Employee Changes
Official Site Inspections
http://www.telabio.com Semrush global rank: 5.44 M Semrush visits lastest month: 1.37 K
- Host name: 84.88.212.35.bc.googleusercontent.com
- IP address: 35.212.88.84
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "TELA Bio"
About Us - TELA Bio
At TELA Bio, we’re obsessively focused on creating solutions for gaps in soft-tissue surgical innovation that can improve patient outcomes. To us, this means providing innovative soft …See details»
TELA Bio | Surgical Reconstruction Company
Experience the only biologic reinforced with interwoven polymer suture designed specifically for plastic and reconstructive surgery. Our next generation reinforced biologic is purposefully designed for consistency in stretch, permeability and …See details»
TELA Bio - Crunchbase Company Profile & Funding
TELA Bio reported a reduced loss per share of US$0.23 in the first quarter of 2024, compared to a loss of US$0.63 in the same period in 2023. The …See details»
Investors - TELA Bio
The Company’s corporate headquarters are located at 1 Great Valley Parkway, Suite 24, Malvern, PA 19355 and our telephone number is (484) 320-2930.See details»
TELA Bio - LinkedIn
TELA Bio | 5,582 followers on LinkedIn. Providing clinical solutions for the preservation and restoration of anatomy by leveraging natural healing responses. | We are focused on providing ...See details»
TELA Bio - businessabc.net
Mar 1, 2025 TELA Bio was founded in 2011 with the mission of delivering transformational surgical experience toward improved patient outcomes. The company initially developed a line …See details»
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 …
Operating expenses were $23.9 million in the fourth quarter of 2023, compared to $17.6 million in the same period in 2022. The increase was due to higher compensation costs and employee …See details»
TELA Bio Surgical Reconstruction Company Official …
PURPOSEFULLY DESIGNED UNIQUELY NATURAL. TELA Bio offers unique options for soft tissue repair. Our innovative portfolio of soft tissue solutions combines layers of naturally-sourced tissue with interwoven polymer to enable …See details»
Co-founder, President & CEO at TELA Bio - The Org
Antony Koblish is a medical device entrepreneur with 25 years of experience in health care. Prior to founding TELA Bio, Mr. Koblish was President and Chief Executive Officer of Orthovita, Inc., …See details»
TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results
The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while …See details»
About Us | TELA Bio International
At TELA Bio, we’re obsessively focused on creating solutions for gaps in soft-tissue surgical innovation that can improve patient outcomes. To us, this means providing innovative soft …See details»
TELA Bio Appoints Greg Firestone as Chief Commercial
May 20, 2024 For more information, visit www.telabio.com. Caution Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of The …See details»
TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial ...
The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while …See details»
Legal - TELA Bio
OPT OUT: You may opt-out of this mandatory arbitration provision by writing us within sixty (60) calendar days of your agreement to this arbitration provision, either (a) via email at …See details»
TELA Bio Company Information - Funding, Investors, and More
*****@telabio.com-linkedin: Funding. Funding series. Funding Series Analysis. The company TELA Bio has raised a total of $32m in funding over 3 rounds. Key Insights: TELA Bio , March …See details»
TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results
2 days ago Gross profit was $11.2 million in the fourth quarter of 2024, or 64% of revenue, compared to $11.6 million, or 68% of revenue, in the same period in 2023.See details»
TELA Bio (TELA) Earnings Date and Reports 2025 - MarketBeat
4 days ago TELA Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn …See details»
TELA Bio Announces Closing of Public Offering of Common
MALVERN, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, …See details»
TELA Bio International | Surgical Reconstruction Company
Our growing product portfolio is purposefully designed to leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials.See details»
Release Details - TELA Bio, Inc.
24-Month BRAVO study results showed a 2.6% recurrence rate in diverse clinical scenarios Robotic Reinforced Biologic Augmented Repair (ReBAR) study showed a 1.9% recurrence …See details»